Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Silvia Messina"'
Autor:
Sara Samadzadeh, Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjaer, Michael Levy, Axel Petzold, Jacqueline Palace, Eoin P. Flanagan, Sara Mariotto, Soeren T. Skou, Anne Froelich, Itay Lotan, Silvia Messina, Ruth Geraldes, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Vahid Shaygannejad, Mohammad Ali Sahraian, Ho Jin Kim, Jeffrey L. Bennett, Chotima Böttcher, Hanna G. Zimmermann, Brian G. Weinshenker, Friedemann Paul, Nasrin Asgari
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Comorbidities in patients with multiple sclerosis (MS) and antibody-mediated diseases of the central nervous system (CNS) including neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein (MOG)-antibody-associated dise
Externí odkaz:
https://doaj.org/article/2b740f34241942d389bbfe03e7b0adef
Autor:
Tianrong Yeo, Giordani Rodrigues dosPassos, Louwai Muhammed, Rosie Everett, Sandra Reeve, Silvia Messina, Fay Probert, Maria Isabel Leite, Jacqueline Palace
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 3, Pp 375-383 (2020)
Abstract Objective Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin‐4 (AQP4) and myelin oligod
Externí odkaz:
https://doaj.org/article/f1004fe4826349998358d3e7eb878619
Autor:
George Tackley, Yazhuo Kong, Rachel Minne, Silvia Messina, Anderson Winkler, Ana Cavey, Rosie Everett, Gabriele C DeLuca, Andrew Weir, Matthew Craner, Irene Tracey, Jacqueline Palace, Charlotte J Stagg, Uzay Emir
Publikováno v:
NeuroImage, Vol 238, Iss , Pp 118225- (2021)
Magnetic Resonance Spectroscopy (MRS) allows for the non-invasive quantification of neurochemicals and has the potential to differentiate between the pathologically distinct diseases, multiple sclerosis (MS) and AQP4Ab-positive neuromyelitis optica s
Externí odkaz:
https://doaj.org/article/ff0bc0aa1ae544aeb01177581f193841
Autor:
Silvia Messina, Claudio Solaro, Isabella Righini, Roberto Bergamaschi, Simona Bonavita, Roberto Bruno Bossio, Vincenzo Brescia Morra, Gianfranco Costantino, Paola Cavalla, Diego Centonze, Giancarlo Comi, Salvatore Cottone, Maura Chiara Danni, Ada Francia, Alberto Gajofatto, Claudio Gasperini, Mauro Zaffaroni, Loredana Petrucci, Elisabetta Signoriello, Giorgia Teresa Maniscalco, Gabriella Spinicci, Manuela Matta, Massimiliano Mirabella, Graziella Pedà, Letizia Castelli, Marco Rovaris, Edoardo Sessa, Daniele Spitaleri, Damiano Paolicelli, Alfredo Granata, Mario Zappia, Francesco Patti, SA.FE. study group
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0180651 (2017)
The approval of Sativex for the management of multiple sclerosis (MS) spasticity opened a new opportunity to many patients. In Italy, the healthcare payer can be fully reimbursed by the involved pharma company with the cost of treatment for patients
Externí odkaz:
https://doaj.org/article/708f45afdbee4c38ad1ddae8ac4f4507
Publikováno v:
European Medical Journal Neurology, Vol 1, Iss 1, Pp 32-37 (2013)
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearing age. Little is known about the possible association between mode of delivery and the risk of MS in offspring. Delivery repres
Externí odkaz:
https://doaj.org/article/3a1689fed1b342b4870ab9483eaae377
Autor:
Francesco Patti, Manuela De Stefano, Luigi Lavorgna, Silvia Messina, Clara Grazia Chisari, Domenico Ippolito, Roberta Lanzillo, Veria Vacchiano, Sabrina Realmuto, Paola Valentino, Gabriella Coniglio, Maria Buccafusca, Damiano Paolicelli, Alessandro D'Ambrosio, Patrizia Montella, Vincenzo Brescia Morra, Giovanni Savettieri, Bruno Alfano, Antonio Gallo, Isabella Simone, Rosa Viterbo, Mario Zappia, Simona Bonavita, Gioacchino Tedeschi
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120754 (2015)
Magnetic Resonance Imaging (MRI) techniques provided evidences into the understanding of cognitive impairment (CIm) in Multiple Sclerosis (MS).To investigate the role of white matter (WM) and gray matter (GM) in predicting long-term CIm in a cohort o
Externí odkaz:
https://doaj.org/article/2697625ee8d74c94bf01033fb7ada2b1
Autor:
Silvia Messina, Francesco Patti
Publikováno v:
Multiple Sclerosis International, Vol 2014 (2014)
Multiple sclerosis (MS) is an immune-mediated disease affecting central nervous system (CNS). Although MS is classically considered a white matter (WM) disease, the involvement of gray matter (GM) in the pathogenic process has been confirmed by patho
Externí odkaz:
https://doaj.org/article/b193ac7bf3dd4e23a61bdd0f21684d05
Autor:
Alessandra Nicoletti, Elisa Bruno, Martina Nania, Edoardo Cicero, Silvia Messina, Clara Chisari, Josita Torrisi, Davide Maimone, Roberto Marziolo, Salvatore Lo Fermo, Francesco Patti, Salvatore Giammanco, Mario Zappia
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e74259 (2013)
BackgroundTrace elements have been hypothesised to be involved in the pathogenesis of Multiple Sclerosis and volcanic degassing is the major natural sources of trace elements. Both incidence of Multiple Sclerosis in Catania and volcanic activity of M
Externí odkaz:
https://doaj.org/article/bfe80f1c6b3c4f4b8dac4b7aa901d8b2
Autor:
Francesco Patti, Alessandra Nicoletti, Carmela Leone, Silvia Messina, Emanuele D'Amico, Salvatore Lo Fermo, Vincenza Paradisi, Elisa Bruno, Graziella Quattrocchi, Pierfrancesco Veroux, Luigi Di Pino, Luca Costanzo, Mario Zappia
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e41227 (2012)
BackgroundChronic cerebrospinal venous insufficiency (CCSVI) has been associated to multiple sclerosis (MS).ObjectiveTo evaluate the possible association between CCSVI and MS, using a population-based control design.MethodsA random cohort of 148 inci
Externí odkaz:
https://doaj.org/article/eb0b721496014156b49e28a85b707aef
Autor:
Francesco Patti, Maria Pia Amato, Stefano Bastianello, Luisa Caniatti, Elisabetta Di Monte, Fausto Lijoi, Benedetta Goretti, Silvia Messina, Orietta Picconi, Maria Rosalia Tola, Maria Trojano
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 2 (2009)
The effect of interferon (IFN) beta-1a (44 and 22 μg subcutaneously [sc] three times weekly [tiw]) on cognition in mildly disabled patients with relapsing—remitting multiple sclerosis (McDonald criteria; Expanded Disability Status Scale ≤4.0) wa
Externí odkaz:
https://doaj.org/article/2cbe533f521545ab87229a3de8b80404